FDA Approved: HALOPERIDOL DECANOATE — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved haloperidol decanoate under an original ANDA from Meitheal Pharmaceuticals as a long-acting injectable antipsychotic indicated for schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• HALOPERIDOL DECANOATE (Haloperidol decanoate)

Snippet

ORIG AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)